Cutting-edge AI is great, but how will your health system pay for it?

Optellum is the only Lung Nodule AI with named reimbursement by CMS 5 years and running. ^{1, 2, 3, 4, 5}

Our US health system partners are billing and being reimbursed for using Optellum’s Lung Cancer Prediction (LCP) AI today. We help remove the financial risks often associated with cutting-edge AI adoption. While other tools offer promises, Optellum delivers.

That’s why leading pulmonary, thoracic oncology, and radiology programs across the US choose Optellum to help drive earlier diagnoses, service line growth, and more confident Lung Cancer Care decisions. ⁶

Learn more, visit our Reimbursement page

Sources:

[1] 2026 HOPPS

[2] 2025 HOPPS

[3] 2024 HOPPS

[4] 2023 HOPPS

[5] 2022

[6] Optellum publications page